These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Infusion phlebitis; selected factors. Ross SA Nurs Res; 1972; 21(4):313-8. PubMed ID: 4483283 [No Abstract] [Full Text] [Related]
27. A method for reducing the incidence of infusion phlebitis. Weiss Y; Nissan S Surg Gynecol Obstet; 1975 Jul; 141(1):73-4. PubMed ID: 1154216 [TBL] [Abstract][Full Text] [Related]
28. [Heparinoids versus nitroglycerin in the treatment of superficial phlebitis]. Almenar L; Hernández M; Gimeno JV; Palencia M; Algarra F Rev Clin Esp; 1993 Oct; 193(5):229-31. PubMed ID: 8256008 [TBL] [Abstract][Full Text] [Related]
29. Post-infusion phlebitis. Phatak AT; Shah SB Indian Pediatr; 1972 Oct; 9(10):599-604. PubMed ID: 4657779 [No Abstract] [Full Text] [Related]
30. Personnel--induced infusion phlebitis. Cosentino F Bull Parenter Drug Assoc; 1977; 31(6):288-93. PubMed ID: 597648 [No Abstract] [Full Text] [Related]
31. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis. Evans WE; Barker LF; Simone JV Am J Hosp Pharm; 1976 Nov; 33(11):1160-3. PubMed ID: 998633 [TBL] [Abstract][Full Text] [Related]
32. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics. Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794 [TBL] [Abstract][Full Text] [Related]
33. The importance of frequent examination of infusion sites in preventing postinfusion phlebitis. Arnold RE; Elliot EK; Holmes BH Surg Gynecol Obstet; 1977 Jul; 145(1):19-20. PubMed ID: 877819 [No Abstract] [Full Text] [Related]
35. Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer. Ikeda S; Douchi T; Nagata Y J Obstet Gynaecol Res; 2004 Dec; 30(6):427-9. PubMed ID: 15566456 [TBL] [Abstract][Full Text] [Related]
36. [Risk factors for the development of phlebitis in peripheral infusions]. Klaver NS; Hermans J; Ulrich C Ned Tijdschr Geneeskd; 1998 Feb; 142(8):405-9. PubMed ID: 9562775 [TBL] [Abstract][Full Text] [Related]
37. Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip. Siegman-Igra Y; Jacobi E; Lang R; Schwartz D; Carmeli Y J Hosp Infect; 2005 Jun; 60(2):122-8. PubMed ID: 15866010 [TBL] [Abstract][Full Text] [Related]
38. Suppurative phlebitis of an arm vein from a "scalp-vein needle". Maki DG; Drinka PJ; Davis TE N Engl J Med; 1975 May; 292(21):1116-7. PubMed ID: 1093020 [No Abstract] [Full Text] [Related]
39. Peripheral intravenous catheter-related phlebitis and related risk factors. Nassaji-Zavareh M; Ghorbani R Singapore Med J; 2007 Aug; 48(8):733-6. PubMed ID: 17657380 [TBL] [Abstract][Full Text] [Related]
40. Effect of two different short peripheral catheter materials on phlebitis development. Karadağ A; Görgülü S J Intraven Nurs; 2000; 23(3):158-66. PubMed ID: 11272972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]